SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF, a New Plateau -- Ignore unavailable to you. Want to Upgrade?


To: Extra Pale who wrote (1033)3/24/2002 4:29:48 PM
From: scaram(o)uche  Respond to of 2243
 
>> a smart pharma acquires ELN in 2003 for something under $20/share <<

In that case, KELAB (strike 10) would be about break even, after a patient wait? Everything out of the money would be a downer at best and perhaps a 100% loss.

I don't see it happening. I can see the miss on forecast, but -- by 2003 -- it seems like rationale will have returned re. capitalization. Sobering comment, however.

Kansas looks great. GREAT.